European Union - English - EMA (European Medicines Agency)

laboratoire francais du fractionnement et des biotechnologies - antithrombin alfa - antithrombin iii deficiency - antithrombotic agents - atryn is indicated for the prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency. atryn is normally given in association with heparin or low molecular weight heparin.

European Union - English - EMA (European Medicines Agency)

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i.e. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu

United States - English - NLM (National Library of Medicine)

laboratoire français du fractionnement et des biotechnologies société anonyme (lfb s.a.) - coagulation factor viia recombinant human (unii: ac71r787ov) (coagulation factor viia recombinant human - unii:ac71r787ov) - sevenfact  [coagulation factor viia (recombinant)-jncw] is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia a or b with inhibitors.  limitation of use: sevenfact is not indicated for the treatment of patients with congenital factor vii deficiency. sevenfact is contraindicated in - known allergy to rabbits or rabbit proteins. exposure to sevenfact in these patients can result in severe hypersensitivity reaction.  - patients with severe hypersensitivity reaction to sevenfact or any of its components. exposure to sevenfact in these patients can result in severe hypersensitivity reaction.  risk summary there are no adequate and well-controlled studies using sevenfact in pregnant women to determine whether there is a drug-associated risk. animal studies evaluating the embryo-fetal teratogenic potential of sevenfact have not been conducted. it is unknown whether sevenfact can cause fetal harm when administered to a pregnant

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire français du fractionnement et des biotechnologies s.a. - human fibrinogen humain 1,5 g - powder and solvent for solution for injection/infusion - 1,5 g - human fibrinogen 1.5 g - fibrinogen, human

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire français du fractionnement et des biotechnologies s.a. - human normal immunoglobulin 100 mg/ml - solution for infusion - 100 mg/ml - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire français du fractionnement et des biotechnologies s.a. - human normal immunoglobulin 100 mg/ml - solution for infusion - immunoglobulins, normal human, for intravascular adm.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire français du fractionnement et des biotechnologies s.a. - human normal immunoglobulin 100 mg/ml - solution for infusion - immunoglobulins, normal human, for intravascular adm.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoire français du fractionnement et des biotechnologies s.a. - human normal immunoglobulin 100 mg/ml - solution for infusion - immunoglobulins, normal human, for intravascular adm.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lfb biopharmaceuticals ltd - human fibrinogen - powder and solvent for solution for infusion - 1.5gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lfb biopharmaceuticals ltd - normal immunoglobulin human - solution for infusion - 100mg/1ml